Offer - Urjas Oil for just ₹ 1 X
Luporal Capsule (10) is a prescription drug, available for use as Capsule. It is primarily used for the treatment of Colorectal Cancer, Colorectal Cancer. The alternative uses of Luporal Capsule (10) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Luporal Capsule (10). Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Luporal Capsule (10) also has some side effects, the most common being Skin Rash. Besides the aforementioned side effects, there are other adverse effects of Luporal Capsule (10) as well, which are listed below. Normally, these side effects of Luporal Capsule (10) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Luporal Capsule (10) has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Luporal Capsule (10) related warnings talks about Luporal Capsule (10)'s effects on the liver, heart and kidney.
Luporal Capsule (10) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Mouth Ulcer, Liver Disease, Diarrhea (Loose Motions) are examples of such conditions. The section on Luporal Capsule (10) contraindications lists all such conditions.
Additionally, Luporal Capsule (10) may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Luporal Capsule (10) is safe while driving, and is addiction.
Luporal Capsule (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Luporal Capsule (10) safe for pregnant women?
Luporal can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Luporal Capsule (10) safe during breastfeeding?
Luporal should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Luporal Capsule (10) on the Kidneys?
Luporal is completely safe for kidneys.
What is the effect of Luporal Capsule (10) on the Liver?
There may be an adverse effect on the liver after taking Luporal. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Luporal Capsule (10) on the Heart?
There are no any side effects of Luporal for the heart.
Luporal Capsule (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Luporal Capsule (10) unless your doctor advises you to do so -
Is this Luporal Capsule (10) habit forming or addictive?
Luporal Capsule (10) is not addictive in nature.
Interaction between Food and Luporal Capsule (10)
Due to the absence of research, it is difficult to say how Luporal Capsule (10) and food will interact.
Interaction between Alcohol and Luporal Capsule (10)
Information about the interaction of Luporal Capsule (10) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fluorouracil
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 864
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 585-588